Moderna Inc (NASDAQ:MRNA) shares are trading higher by 7.2% at $163.54 Wednesday afternoon after Deutsche Bank upgraded the stock from Sell to Hold and announced a $175 price target.
Shares of vaccine companies were otherwise trading lower during Tuesday's session. Over the past 4 trading sessions, Moderna's stock has fallen approximately 12.6% from the $175 level to the $152 level.